Dimerix

Dimerix Equity Ratio

The Equity Ratio of Dimerix (DXB.AX) as of Oct 11, 2026 is -25.19 %. In the previous year, Equity Ratio was 14.67 % — a change of -271.63% (lower).

Equity Ratio

-25.19 %

YoY

-271.63%

Last updated:

Equity Ratio of Dimerix is 2026 -25.19 % . Equity Ratio of Dimerix was 2025 14.67 % . It decreases by -271.63% lower compared to the previous year.

The Dimerix Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
85.07 AUD
Jan 1, 2020
74.69 AUD
Jan 1, 2021
15.59 AUD
Jan 1, 2022
87.43 AUD
Jan 1, 2023
33.58 AUD
Jan 1, 2024
56.69 AUD
Jan 1, 2025
14.67 AUD
Jan 1, 2026
-25.19 AUD
The Dimerix Equity Ratio history
YEAREquity RatioYoY
-25.19 %-271.63%
14.67 %-74.12%
56.69 %+68.82%
33.58 %-61.59%
87.43 %+460.85%
15.59 %-79.13%
74.69 %-12.20%
85.07 %-9.89%
94.40 %+3.09%
91.57 %+3.11%
88.80 %-5.07%
93.54 %+5,180.58%
1.77 %—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Equity Ratio of Dimerix is -25.19 % in 2026.

Equity Ratio of Dimerix changed from 14.67 % to -25.19 %, representing a -271.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Dimerix since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Dimerix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Dimerix

All Key Metrics — Dimerix